1-3 of 3
Kenichi Kitazoe, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SB431542, a TGF-Beta Receptor Kinase Inhibitor, Restores Bone Formation Which Ameliorates Myeloma-Induced Microenvironment.

Kyoko Takeuchi, MD, Masahiro Abe, MD, Asuka Oda, MT, Hiroe Amou, MT, Masahiro Hiasa, DDS, Jin Asano, MD, Kenichi Kitazoe, MD, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Shinsuke Kido, PhD, Daisuke Inoue, MD, Toshio Matsumoto, MD
Journal: Blood
Blood (2006) 108 (11): 3479.
https://doi.org/10.1182/blood.V108.11.3479.3479
Published: 2006
Journal Articles

Emerging of Valproic Acid as an Anti-Myeloma Agent.

Kenichi Kitazoe, MD, Masahiro Abe, MD, Masahito Choraku, MD, Kumiko Kagawa, MD, Jin Asano, MD, Kyoko Takeuchi, MD, Masahiro Hiasa, DDS, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Asuka Oda, MT, Hiroe Amou, MT, Toshio Matsumoto, MD
Journal: Blood
Blood (2006) 108 (11): 3482.
https://doi.org/10.1182/blood.V108.11.3482.3482
Published: 2006
Journal Articles

Myeloma Cells Suppress Osteoblast Differentiation by Secreting a Soluble Wnt Inhibitor, sFRP-2.

Takashi Oshima, MD, Masahiro Abe, MD, Jin Asano, MD, Tomoko Hara, MD, Kenichi Kitazoe, MD, Etsuko Sekimoto, MD, Yoichi Tanaka, MD, Hironobu Shibata, MD, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Shinsuke Kido, MD, Daisuke Inoue, MD, Toshio Matsumoto, MD
Journal: Blood
Blood (2004) 104 (11): 2356.
https://doi.org/10.1182/blood.V104.11.2356.2356
Published: 2004